Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24h after oral administration in dogs

Orsolya Nagy, Ágnes Hajnal, J. Parratt, A. Végh

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Sildenafil (Viagra) prolongs repolarisation in cardiac muscle, an effect that could lead to ventricular fibrillation (VF). Sildenafil (2 mg kg -1) was given by mouth to 12 mongrel dogs and, 24 h later, these dogs were anaesthetised, thoracotomised and subjected to a 25 min occlusion of the anterior descending coronary artery. Haemodynamic parameters were similar in this and the control group, but there were fewer and less serious ventricular arrhythmias during occlusion in the sildenafil group (VF 17 vs 60%; ventricular premature beats 140 ± 52 vs 437 ± 127% and episodes of ventricular tachycardia 4.0 ± 3.2 vs 19.3 ± 7.7%, all P <0.05). However, reperfusion VF and indices of ischaemia severity (epicardial ST-segment mapping, inhomogeneity) were not modified by the drug. Sildenafil increased the QT interval, especially during ischaemia. Our conclusion is that ischaemia-induced ventricular arrhythmias are reduced by sildenafil, but this protection is less pronounced than that following cardiac pacing or exercise.

Original languageEnglish
Pages (from-to)549-551
Number of pages3
JournalBritish Journal of Pharmacology
Volume141
Issue number4
DOIs
Publication statusPublished - Feb 2004

Fingerprint

Oral Administration
Cardiac Arrhythmias
Ischemia
Dogs
Ventricular Fibrillation
Ventricular Premature Complexes
Ventricular Tachycardia
Reperfusion
Mouth
Sildenafil Citrate
Coronary Vessels
Myocardium
Hemodynamics
Control Groups
Pharmaceutical Preparations

Keywords

  • Delayed preconditioning
  • Myocardial ischaemia
  • Sildenafil
  • Ventricular arrhythmias
  • Viagra

ASJC Scopus subject areas

  • Pharmacology

Cite this

Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24h after oral administration in dogs. / Nagy, Orsolya; Hajnal, Ágnes; Parratt, J.; Végh, A.

In: British Journal of Pharmacology, Vol. 141, No. 4, 02.2004, p. 549-551.

Research output: Contribution to journalArticle

@article{4301fe3c626a4358bc60e50c05e80196,
title = "Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24h after oral administration in dogs",
abstract = "Sildenafil (Viagra) prolongs repolarisation in cardiac muscle, an effect that could lead to ventricular fibrillation (VF). Sildenafil (2 mg kg -1) was given by mouth to 12 mongrel dogs and, 24 h later, these dogs were anaesthetised, thoracotomised and subjected to a 25 min occlusion of the anterior descending coronary artery. Haemodynamic parameters were similar in this and the control group, but there were fewer and less serious ventricular arrhythmias during occlusion in the sildenafil group (VF 17 vs 60{\%}; ventricular premature beats 140 ± 52 vs 437 ± 127{\%} and episodes of ventricular tachycardia 4.0 ± 3.2 vs 19.3 ± 7.7{\%}, all P <0.05). However, reperfusion VF and indices of ischaemia severity (epicardial ST-segment mapping, inhomogeneity) were not modified by the drug. Sildenafil increased the QT interval, especially during ischaemia. Our conclusion is that ischaemia-induced ventricular arrhythmias are reduced by sildenafil, but this protection is less pronounced than that following cardiac pacing or exercise.",
keywords = "Delayed preconditioning, Myocardial ischaemia, Sildenafil, Ventricular arrhythmias, Viagra",
author = "Orsolya Nagy and {\'A}gnes Hajnal and J. Parratt and A. V{\'e}gh",
year = "2004",
month = "2",
doi = "10.1038/sj.bjp.0705658",
language = "English",
volume = "141",
pages = "549--551",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Sildenafil (Viagra) reduces arrhythmia severity during ischaemia 24h after oral administration in dogs

AU - Nagy, Orsolya

AU - Hajnal, Ágnes

AU - Parratt, J.

AU - Végh, A.

PY - 2004/2

Y1 - 2004/2

N2 - Sildenafil (Viagra) prolongs repolarisation in cardiac muscle, an effect that could lead to ventricular fibrillation (VF). Sildenafil (2 mg kg -1) was given by mouth to 12 mongrel dogs and, 24 h later, these dogs were anaesthetised, thoracotomised and subjected to a 25 min occlusion of the anterior descending coronary artery. Haemodynamic parameters were similar in this and the control group, but there were fewer and less serious ventricular arrhythmias during occlusion in the sildenafil group (VF 17 vs 60%; ventricular premature beats 140 ± 52 vs 437 ± 127% and episodes of ventricular tachycardia 4.0 ± 3.2 vs 19.3 ± 7.7%, all P <0.05). However, reperfusion VF and indices of ischaemia severity (epicardial ST-segment mapping, inhomogeneity) were not modified by the drug. Sildenafil increased the QT interval, especially during ischaemia. Our conclusion is that ischaemia-induced ventricular arrhythmias are reduced by sildenafil, but this protection is less pronounced than that following cardiac pacing or exercise.

AB - Sildenafil (Viagra) prolongs repolarisation in cardiac muscle, an effect that could lead to ventricular fibrillation (VF). Sildenafil (2 mg kg -1) was given by mouth to 12 mongrel dogs and, 24 h later, these dogs were anaesthetised, thoracotomised and subjected to a 25 min occlusion of the anterior descending coronary artery. Haemodynamic parameters were similar in this and the control group, but there were fewer and less serious ventricular arrhythmias during occlusion in the sildenafil group (VF 17 vs 60%; ventricular premature beats 140 ± 52 vs 437 ± 127% and episodes of ventricular tachycardia 4.0 ± 3.2 vs 19.3 ± 7.7%, all P <0.05). However, reperfusion VF and indices of ischaemia severity (epicardial ST-segment mapping, inhomogeneity) were not modified by the drug. Sildenafil increased the QT interval, especially during ischaemia. Our conclusion is that ischaemia-induced ventricular arrhythmias are reduced by sildenafil, but this protection is less pronounced than that following cardiac pacing or exercise.

KW - Delayed preconditioning

KW - Myocardial ischaemia

KW - Sildenafil

KW - Ventricular arrhythmias

KW - Viagra

UR - http://www.scopus.com/inward/record.url?scp=1842610702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842610702&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0705658

DO - 10.1038/sj.bjp.0705658

M3 - Article

C2 - 14744808

AN - SCOPUS:1842610702

VL - 141

SP - 549

EP - 551

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -